ClinicalTrials.gov
public full text
Public Domain
Therapeutic HPV-16 Vaccination for the Treatment of Anal Dysplasia
The objective of the study is to assess, in a phase 1/2 study, the safety and efficacy of this synthetic vaccine SLP-HPV-01® in HIV+ men with CD4 counts \> 350 x 10E6/l and HPV16-induced intra-anal high-grade AIN (grade 2-3) that failed on, or recurred after previous treatment.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Conventional cytologic diagnosis of HPV-induced anal intraepithelial neoplasia: the experience of a referral center in Rio de Janeiro, Brazil#1029305
- Screening Anal HPV Colonization in Men Sex Men Using Pre-exposure Prophylaxis for HIV (ANAPreP'HPV)#911888
- Quadrivalent HPV Vaccine to Prevent Anal HPV in HIV-infected Men and Women#154715
- Overlooked Population at Risk for AIN.#855118
- Human Papillomavirus Anal Infection#1007202
Record · ID 1364448
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive